HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells

Cell Death and Differentiation

Volumn 19, Issue 1, 2012, Pages 96-106

  Gougeon, M L ^a   Melki, M T ^a   Sadi, H ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

dendritic cell; HIV; HMGB1; natural killer cell; TRAIL

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN;

ANTIVIRAL ACTIVITY; CELL FATE; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOID TISSUE; MOLECULAR INTERACTION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VIRUS LATENCY; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ANIMALS; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HMGB1 PROTEIN; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MICE; MYELOID CELLS; NF-KAPPA B; TH1 CELLS; TOLL-LIKE RECEPTOR 4; VIRUS LATENCY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84856745299     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.134     Document Type: Review

References (96)

1. Thomas JO, Travers AA. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem Sci 2001; 26: 167-174. (Pubitemid 32197576)
2. Ciubotaru M, Schatz DG. Synapsis of recombination signal sequences located in cis and DNA underwinding in V(D)J recombination. Mol Cell Biol 2004; 24: 8727-8744. (Pubitemid 39245091)
3. Stros M, Ozaki T, Bacikova A, Kageyama H, Nakagawara A. HMGB1 and HMGB2 cellspecifically down-regulate the p53-and p73-dependent sequence-specific transactivation from the human Bax gene promoter. J Biol Chem 2002; 277: 7157-7164. (Pubitemid 34953105)
4. Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 2004; 18: 1272-1282. (Pubitemid 38720595)
5. Stros M, Muselikova-Polanska E, Pospisilova S, Strauss F. High-affinity binding of tumorsuppressor protein p53 and HMGB1 to hemicatenated DNA loops. Biochemistry 2004; 43: 7215-7225. (Pubitemid 38720539)
6. Knapp S, Muller S, Digilio G, Bonaldi T, Bianchi ME, Musco G. The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes. Biochemistry 2004; 43: 11992-11997. (Pubitemid 39280544)
7. Tang DL, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010; 190: 881-892.
8. Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu Y et al. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia 2011; 25: 23-31.
9. Wang HC, Bloom O, Zhang MH, Vishnubhakat JM, Ombrellino M, Che JT et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-251. (Pubitemid 29329996)
10. Oppenheim JJ, Tewary P, de la Rosa G, Yang D. Alarmins initiate host Defense In: Shurin MR, Smolkin YS (eds) Immune-Mediated Diseases: from Theory to Therapy 2007, pp 185-194.
11. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 2007; 81: 59-66. (Pubitemid 46021253)
12. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81: 1-5. (Pubitemid 46028489)
13. Yang H, Yuan RQ, Wang HC, Ochani M, Tracey KJ. Role of HMGB1 in apoptosis-mediated sepsis lethality. Inflamm Res 2007; 56: S88-S89.
14. Pisetsky DS, Erlandsson-Harris H, Andersson U. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther 2008; 10: 209.
15. Abdulahad DA, Westra J, Limburg PC, Kallenberg CGM, Bijl M. HMGB1 in systemic lupus erythematosus: its role in cutaneous lesions development. Autoimmun Rev 2010; 9: 661-665.
16. Wang HC, Ward MF, Fan XG, Sama AE, Li W. Potential role of high mobility group box 1 in viral infectious diseases. Viral Immunol 2006; 19: 3-9.
17. Nowak P, Barqasho B, Sonnerborg A. Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infection. AIDS 2007; 21: 869-871. (Pubitemid 46573160)
18. Ivanov S, Dragoi AM, Wang X, Dallacosta C, Louten J, Musco G et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007; 110: 1970-1981. (Pubitemid 47443911)
19. Nowak P, Barqasho B, Treutiger CJ, Harris HE, Tracey KJ, Andersson J et al. HMGB1 activates replication of latent HIV-1 in a monocytic cell-line, but inhibits HIV-1 replication in primary macrophages. Cytokine 2006; 34: 17-23. (Pubitemid 43817548)
20. Cassetta L, Fortunato O, Adduce L, Rizzi C, Hering J, Rovere-Querini P et al. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines. AIDS 2009; 23: 567-577.
21. Saidi H, Melki MT, Gougeon ML. HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk. Plos One 2008; 3: e3601.
22. Melki MT, Saidi H, Dufour A, Olivo-Marin JC, Gougeon ML. Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk-a pivotal role of HMGB1. Plos Pathog 2010; 6: e1000862.
23. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449: 819-826. (Pubitemid 47598622)
24. Yanai H, Ban T,Wang ZC, Choi MK, Kawamura T, Negishi H et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009; 462: U99-U110.
25. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007; 8: 487-496. (Pubitemid 46605917)
26. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195. (Pubitemid 34773774)
27. Raucci A, Palumbo R, Bianchi ME. HMGB1: a signal of necrosis. Autoimmunity 2007; 40: 285-289. (Pubitemid 46845522)
28. Lamkanfi M, Sarkar A, Walle LV, Vitari AC, Amer AO, Wewers MD et al. Inflammasomedependent release of the alarmin HMGB1 in endotoxemia. Nat Immunol 2010; 185: 4385-4392.
29. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol 2005; 26: 381-387. (Pubitemid 40835844)
30. Rendon-Mitchell B, Ochani M, Li JH, Hang JL, Wang H, Yang H et al. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 2003; 170: 3890-3897. (Pubitemid 36361997)
31. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. Embo Rep 2002; 3: 995-1001. (Pubitemid 35256475)
32. Hoppe G, Talcott KE, Bhattacharya SK, Crabb JW, Sears JE. Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp Cell Res 2006; 312: 3526-3538. (Pubitemid 44470773)
33. Youn JH, Shin JS. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 2006; 177: 7889-7897.
34. Ito I, Fukazawa J, Yoshida M. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J Biol Chem 2007; 282: 16336-16344. (Pubitemid 47100350)
35. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. Embo J 2003; 22: 5551-5560. (Pubitemid 37279964)
36. Oh YJ, Youn JH, Ji Y, Lee SE, Lim KJ, Choi JE et al. HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism. J Immunol 2009; 182: 5800-5809.
37. Urbonaviciute V, Meister S, Furnrohr BG, Frey B, Guckel E, Schett G et al. Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis. Autoimmunity 2009; 42: 305-307.
38. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008; 29: 21-32. (Pubitemid 351952462)
39. Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecularpattern molecules (DAMPs) and redox. Trends Immunol 2007; 28: 429-436. (Pubitemid 47444554)
40. Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-Querini P. The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol 2007; 81: 84-91. (Pubitemid 46021256)
41. Manfredi AA, Capobianco A, Esposito A, De Cobelli F, Canu T, Monno A et al. Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol 2008; 180: 2270-2275.
42. Messmer D, Yang H, Telusma G, Knoll F, Li JH, Messmer B et al. High mobility group box protein 1: An endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 2004; 173: 307-313. (Pubitemid 38797355)
43. Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 2005; 174: 7506-7515. (Pubitemid 40806253)
44. Campana L, Bosurgi L, Bianchi ME, Manfredi AA, Rovere-Querini P. Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J Leukoc Biol 2009; 86: 609-615.
45. Chen GY, Tang J, Zheng P, Liu Y. CD24 and siglec-10 selectively repress tissue damageinduced immune responses. Science 2009; 323: 1722-1725.
46. Gougeon ML. Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol 2003; 3: 392-404.
47. Miller CJ, Li QS, Abel K, Kim EY, Ma ZM, Wietgrefe S et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 2005; 79: 9217-9227. (Pubitemid 40934833)
48. Zhang ZQ, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, Reimann KA et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4(+) T cells. Science 1999; 286: 1353-1357.
49. Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464: 217-223.
50. Hu JJ, Gardner MB, Miller CJ. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 2000; 74: 6087-6095. (Pubitemid 30412980)
51. Lanzavecchia A, Sallusto F. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 2001; 13: 291-298. (Pubitemid 32537700)
52. Lambotin M, Raghuraman S, Stoll-Keller F, Baumert TF, Barth H. A look behind closed doors: interaction of persistent viruses with dendritic cells. Nat Rev Microbiol 2010; 8: 350-360.
53. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449: 419-426. (Pubitemid 47509552)
54. McIlroy D, Autran B, Cheynier R, Wainhobson S, Clauvel JP, Oksenhendler E et al. Infection frequency of dendritic cells and CD4(+) T-lymphocytes in spleens of human immunodeficiency virus-positive patients. J Virol 1995; 69: 4737-4745.
55. McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, Hope TJ. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003; 300: 1295-1297. (Pubitemid 36618241)
56. Geijtenbeek TBH, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GCF, Middel J et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100: 587-597.
57. Kwon DS, Gregorio G, Bitton N, Hendrickson WA, Littman DR. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 2002; 16: 135-144. (Pubitemid 34143223)
58. Izquierdo-Useros N, Blanco J, Erkizia I, Fernandez-Figueras MT, Borras FE, Naranjo-Gomez M et al. Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission. J Virol 2007; 81: 7559-7570. (Pubitemid 47047842)
59. Wang JH, Janas AM, Olsonj WJ, Wu L. Functionally distinct transmission of human immunodeficiency virus type mediated by immature and mature dendritic cells. J Virol 2007; 81: 8933-8943. (Pubitemid 47311437)
60. Gould SJ, Booth AM, Hildreth JEK. The Trojan exosome hypothesis. Proc Natl Acad Sci USA 2003; 100: 10592-10597. (Pubitemid 37140073)
61. Izquierdo-Useros N, Naranjo-Gomez M, Erkizia I, Puertas MC, Borras FE, Blanco J et al. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? Plos Pathog 2010; 6: e1000740.
62. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2: 569-579. (Pubitemid 37328732)
63. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998; 4: 594-600. (Pubitemid 28237359)
64. Thery C, Duban L, Segura E, Veron P, Lantz O, Amigorena S. Indirect activation of naive CD4(+) T cells by dendritic cell-derived exosomes. Nat Immunol 2002; 3: 1156-1162. (Pubitemid 35469700)
65. Izquierdo-Useros N, Naranjo-Gomez M, Archer J, Hatch SC, Erkizia I, Blanco J et al. Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 2009; 113: 2732-2741.
66. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999; 5: 405-411. (Pubitemid 29180578)
67. Mailliard RB, Son YI, Redlinger R, Coates PT, Giermasz A, Morel PA et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 2003; 171: 2366-2373. (Pubitemid 37025543)
68. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005; 5: 112-124. (Pubitemid 40208901)
69. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007; 26: 503-517. (Pubitemid 46602996)
70. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5: 1260-1265. (Pubitemid 41057741)
71. Bajenoff M, Breart B, Huang AYC, Qi H, Cazareth J, Braud VM et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 2006; 203: 619-631.
72. Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 2004; 101: 16606-16611. (Pubitemid 39557760)
73. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002; 2: 957-964. (Pubitemid 37323216)
74. Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 2003; 33: 1657.
75. Vitale M, Della Chiesa M, Carlomagno S, Pende D, Arico M, Moretta L et al. NK-dependent DC maturation is mediated by TNF alpha and IFN gamma released upon engagement of the NKp30 triggering receptor. Blood 2005; 106: 566-571. (Pubitemid 40981252)
76. Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 2004; 101: 10116-10121. (Pubitemid 38891204)
77. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002; 195: 335-341. (Pubitemid 34461491)
78. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002; 195: 343-351. (Pubitemid 34461492)
79. Moretta A. The dialogue between human natural killer cells and dendritic cells. Curr Opin Immunol 2005; 17: 306-311. (Pubitemid 40692667)
80. Semino C, Angelini G, Poggi A, Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 2005; 106: 609-616. (Pubitemid 40981258)
81. Semino C, Ceccarelli J, Lotti LV, Torrisi MR, Angelini G, Rubartelli A. The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion. J Leukoc Biol 2007; 81: 92-99. (Pubitemid 46021257)
82. Balsamo M, Zambello R, Teramo A, Pedrazzi M, Sparatore B, Scordamaglia F et al. Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30. Exp Hematol 2009; 37: 1167-1175.
83. Naghavi MH, Nowak P, Andersson J, Sonnerborg A, Yang H, Tracey KJ et al. Intracellular high mobility group B1 protein (HMGB1) represses HIV-1 LTR-directed transcription in a promoter-and cell-specific manner. Virology 2003; 314: 179-189. (Pubitemid 37153308)
84. Thierry S, Gozlan J, Jaulmes A, Boniface R, Nasreddine N, Strauss F et al. High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells. AIDS 2007; 21: 283-292. (Pubitemid 46175041)
85. Andoniou CE, van Dommelen SLH, Voigt V, Andrews DM, Brizard G, Asselin-Paturel C et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 2005; 6: 1011-1019. (Pubitemid 41486186)
86. Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, Ortolano S et al. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 2006; 203: 2339-2350. (Pubitemid 44498368)
87. Tasca S, Tambussi G, Nozza S, Capiluppi B, Zocchi MR, Soldini L et al. Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cellmediated lysis. AIDS 2003; 17: 2291-2298. (Pubitemid 38147014)
88. Alter G, Kavanagh D, Rihn S, Luteijn R, Brooks D, Oldstone M et al. IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. J Clin Invest 2010; 120: 1905-1913.
89. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010; 28: 367-388.
90. Troseid M, Nowak P, Nystrom J, Lindkvist A, Abdurahman S, Sonnerborg A. Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy. AIDS 2010; 24: 1733-1737.
91. Barqasho B, Nowak P, Abdurahman S, Walther-Jallow L, Sonnerborg A. Implications of the release of high-mobility group box 1 protein from dying cells during human immunodeficiency virus type 1 infection in vitro. J Gen Virol 2010; 91: 1800-1809.
92. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12: 1365-1371. (Pubitemid 44924494)
93. Marchetti G, Cozzi-Lepri A, Merlini E, Bellistr?̀ GM, Castagna A, Galli M et al. ICONA Foundation Study Group. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS 2011; 25: 1385-1394.
94. Zhu P, Duan L, Chen J, Xiong A, Xu Q, Zhang H et al. Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. Hum Gene Ther 2011; 7.
95. Bianchi ME. HMGB loves company. J Leukoc Biol 2009; 86: 573-576.
96. Murua Escobar H, Meyer B, Richter A, Becker K, Flohr AM, Bullerdiek J et al. Molecular characterization of the canine HMGB1. Cytogenet Genome Res 2003; 101: 33-38. (Pubitemid 37456638)